· Desk editor: Nadia Hassan · · Single source ·Updated

WHO approves two Ebola vaccines for phase 2 trials in DRC

The World Health Organization announced that two experimental Ebola vaccines will begin phase 2 clinical trials next week in Bunia, Democratic Republic of the Congo.

WHO says 2 Ebola vaccine candidates to enter phase 2 trials next week in DRC
File photo WHO says 2 Ebola vaccine candidates to enter phase 2 trials next week in DRC Photo: Anadolu Agency

Trial start date confirmed

Dr Meg Doherty stated at a Geneva news conference that testing is expected to begin on November 26 or 27. The Tumani randomized controlled trial received approval last week to advance these specific candidates. The Serum Institute of India and Oxford University created the initial vaccine called ChAdOx1. Moderna developed the second candidate for this specific phase of evaluation.

Outbreak statistics and risks

WHO Director-General Tedros Adhanom Ghebreyesus noted the outbreak has surpassed 11,300 cases and 5,500 deaths. Between 400 and 500 new infections are still being reported weekly during this epidemic. Insecurity and attacks on health workers continue to undermine efforts to contain the spread. Delays in identifying infections further discourage people from seeking care at Ebola treatment centers.

Trial expansion plans

More than 140 participants have already enrolled in the study launched on October 23. Researchers plan to add more locations for testing, which should draw in thousands of participants. Mobile teams will deploy to accommodate additional vaccine candidates as they become available. Candidates meeting required criteria will advance to phase 3 for effectiveness evaluation against a comparator.

Reported by one outlet

Only one outlet has published this. Nothing here has been checked against a second report, so read it as that outlet's account and follow the link below for the original.

Reported by

1 independent outlet. Headline as published. Links open the original report.